Gene Editing Market by Product & Service (Reagents, Consumables, Systems, Software), Technology (CRISPR, TALEN, ZFN, Antisense), Application (Cell Line Engineering, Genetic Engineering, Drug Discovery), End User (Pharma, Biotech) – Global Forecast to 2028
The gene editing market is projected to grow from USD 5.3 billion in 2023 to USD 10.6 billion by 2028 at a CAGR of 15.0%. Rising government funding and number of genomics projects has emerged as a high impact driver for the market. In March 2022, the US National Institutes of Health (NIH) expanded its funding for gene editing research, allocating USD 89 million for additional projects. Similarly, the European Union launched the Horizon 2020 program, providing substantial financial resources to promote genomics research and gene editing projects. Moreover, several countries, including China, Japan, and South Korea, have established national genomics programs and dedicated funding to drive advancements in gene editing technologies.
“Gene editing services to witness the highest growth during the forecast period.”
Based on product & service, the gene editing market is segmented into reagents & consumables, software & systems, and services. The gene editing services market includes sequencing services; data analysis; bioinformatics services; and other services, such as informatics, cleanup, gene expression, and DNA synthesis services. Additionally, service providers also offer customized sequencing services. The introduction of sequencing services in biomedical applications is expected to boost the demand for genomic sequencing, subsequently boosting the gene editing market.
“Pharmaceutical & biotechnology companies accounted for the largest share of the global gene editing market in 2022.”
Based on end users, the gene editing market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and other end users. Other end users include diagnostic companies, CROs, and CDMOs. High demand for gene editing in pharma applications such as pharmacogenomics has contributed to the dominance of this segment throughout the forecast period. The growing importance of biomarkers is expected to drive the use of genomic systems and services in this segment, owing to the various applications of biomarkers in drug development. With this, biotechnology companies are also building genomic databases to discover and develop new therapeutics.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
The gene editing market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The Asia Pacific region is expected to be the fastest-growing market for gene editing due to the increasing investments in research and the rising applications of gene synthesis for the genetic engineering of cells and tissues of organisms. Cancer has become one of the leading causes of death in Japan, prompting the government to undertake various initiatives to reduce its prevalence and mortality. For example, the Agency for Medical Research and Development has undertaken many research projects, including the Japan Regenerative Medicine Project, Japan Genomic Medicine Project, and Japan Cancer Research Project. The market in Japan has also witnessed various collaborations and partnerships between local organizations and leading global players seeking to introduce and offer technologically advanced products and services in the country.
Breakdown of supply-side primary interviews, by company type, designation, and region:
This report studies the gene editing market based on product & service, technology, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total gene editing market. The report forecasts the revenue of the market segments with respect to five major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
“Gene editing services to witness the highest growth during the forecast period.”
Based on product & service, the gene editing market is segmented into reagents & consumables, software & systems, and services. The gene editing services market includes sequencing services; data analysis; bioinformatics services; and other services, such as informatics, cleanup, gene expression, and DNA synthesis services. Additionally, service providers also offer customized sequencing services. The introduction of sequencing services in biomedical applications is expected to boost the demand for genomic sequencing, subsequently boosting the gene editing market.
“Pharmaceutical & biotechnology companies accounted for the largest share of the global gene editing market in 2022.”
Based on end users, the gene editing market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and other end users. Other end users include diagnostic companies, CROs, and CDMOs. High demand for gene editing in pharma applications such as pharmacogenomics has contributed to the dominance of this segment throughout the forecast period. The growing importance of biomarkers is expected to drive the use of genomic systems and services in this segment, owing to the various applications of biomarkers in drug development. With this, biotechnology companies are also building genomic databases to discover and develop new therapeutics.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
The gene editing market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The Asia Pacific region is expected to be the fastest-growing market for gene editing due to the increasing investments in research and the rising applications of gene synthesis for the genetic engineering of cells and tissues of organisms. Cancer has become one of the leading causes of death in Japan, prompting the government to undertake various initiatives to reduce its prevalence and mortality. For example, the Agency for Medical Research and Development has undertaken many research projects, including the Japan Regenerative Medicine Project, Japan Genomic Medicine Project, and Japan Cancer Research Project. The market in Japan has also witnessed various collaborations and partnerships between local organizations and leading global players seeking to introduce and offer technologically advanced products and services in the country.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Respondent: Supply Side (70%) , Demand side (30%)
- By Designation: C-level (55%), Director-level (20%), and Others (25%)
- By Region: North America (50%), Europe (20%), AsiaPacific (20%), and Rest of the World(10%)
- Merck KGaA (Germany)
- Thermo Fisher Scientific, Inc. (US)
- GenScript (China)
- Agilent Technologies (US)
- PerkinElmer (US)
- Lonza (Switzerland)
- Tecan Life Sciences (Switzerland)
- Sangamo Therapeutics (US)
- Editas Medicine (US)
- CRISPR Therapeutics AG (Switzerland)
- Precision Biosciences (US)
- Cellectis S.A. (France)
- Intellia Therapeutics (US)
- Bluebird Bio, Inc. (US)
- Regeneron Pharmaceuticals (US)
- AMSBIO (England)
- Creative Biogene (US)
- Synthego Corporation (US)
- Beam Therapeutics Inc. (US)
- Caribou Biosciences, Inc. (US)
- OriGene Technologies (US)
- New England Biolabs (US)
- Inscripta (US)
- Mammoth Biosciences (US).
This report studies the gene editing market based on product & service, technology, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total gene editing market. The report forecasts the revenue of the market segments with respect to five major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on gene editing offered by the top 25 players in the market. The report analyzes the gene editing market by product & service, technology, application, end user, and region.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various products/services/technologies across key geographic regions.
- Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the gene editing market
- Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the gene editing market
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: GENE EDITING MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 GENE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 GENE EDITING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
FIGURE 7 GENE EDITING MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
2.4 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 9 GENE EDITING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 GENE EDITING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 11 GENE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 12 GENE EDITING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT: GENE EDITING MARKET, 2022
4 PREMIUM INSIGHTS
4.1 GENE EDITING MARKET OVERVIEW
FIGURE 14 GROWING INVESTMENTS IN GENOMICS RESEARCH TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 15 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 NORTH AMERICA GENE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 16 CELL LINE ENGINEERING TO DOMINATE NORTH AMERICAN MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 GENOME EDITING MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising government funding and number of genomics projects
5.2.1.2 Growing applications of genomics
5.2.1.3 Introduction of CRISPR-Cas9
5.2.2 RESTRAINTS
5.2.2.1 Off-target effects of CRISPR technology
5.2.3 OPPORTUNITIES
5.2.3.1 Extensive use of genome editing in personalized medicine
5.2.3.2 Expanding pipeline for gene therapy
5.2.4 CHALLENGES
5.2.4.1 High equipment costs
5.3 TECHNOLOGY ANALYSIS
5.4 SUPPLY AND VALUE CHAIN ANALYSIS
5.4.1 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 18 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS
5.4.2 VALUE CHAIN ANALYSIS
FIGURE 19 GENE EDITING MARKET: VALUE CHAIN ANALYSIS
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.6 PRICING ANALYSIS
TABLE 5 AVERAGE SELLING PRICES, BY PRODUCT (KEY PLAYER OFFERINGS)
5.7 REGULATORY ANALYSIS
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 ECOSYSTEM ANALYSIS
FIGURE 21 GENE EDITING MARKET: ECOSYSTEM ANALYSIS
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 11 GENE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY CONFERENCES AND EVENTS IN 2023
TABLE 12 GENE EDITING MARKET: CONFERENCES AND EVENTS (2023)
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 22 GENE EDITING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
5.11.2 GENE EDITING MARKET: BUYING CRITERIA
FIGURE 23 KEY BUYING CRITERIA FOR GENE EDITING
5.12 PATENT ANALYSIS
FIGURE 24 PATENTS GRANTED, JANUARY 2011–JUNE 2023
FIGURE 25 TOP PATENT APPLICANTS, JANUARY 2011–JUNE 2023
6 GENE EDITING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 13 GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 REAGENTS & CONSUMABLES
6.2.1 REAGENTS & CONSUMABLES TO HOLD LARGEST MARKET SHARE
TABLE 14 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 15 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 16 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 17 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 SOFTWARE & SYSTEMS
6.3.1 INCREASING APPLICATIONS OF GENOME EDITING/SEQUENCING TO BOOST DEMAND FOR SYSTEMS AND SOFTWARE
TABLE 19 GENE EDITING SOFTWARE & SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 20 NORTH AMERICA: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 EUROPE: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 ASIA PACIFIC: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 LATIN AMERICA: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SERVICES
6.4.1 RISING DEMAND FOR SERVICES TO SUPPORT GROWTH
TABLE 24 GENE EDITING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 25 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 GENE EDITING MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 29 GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.2 CRISPR
7.2.1 EASE OF USE TO BOOST DEMAND OVER OTHER TECHNOLOGIES
TABLE 30 GENE EDITING MARKET FOR CRISPR, BY REGION, 2021–2028 (USD MILLION)
TABLE 31 NORTH AMERICA: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 EUROPE: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 ASIA PACIFIC: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 LATIN AMERICA: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 TALEN
7.3.1 ABILITY TO MAKE QUICK MODIFICATIONS TO DRIVE USAGE
TABLE 35 GENE EDITING MARKET FOR TALEN, BY REGION, 2021–2028 (USD MILLION)
TABLE 36 NORTH AMERICA: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 EUROPE: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 ASIA PACIFIC: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 LATIN AMERICA: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 ZFN
7.4.1 UTILITY IN EUKARYOTE CELL STUDIES TO DRIVE MARKET GROWTH
TABLE 40 GENE EDITING MARKET FOR ZFN, BY REGION, 2021–2028 (USD MILLION)
TABLE 41 NORTH AMERICA: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 EUROPE: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 LATIN AMERICA: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 ANTISENSE
7.5.1 INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH
TABLE 45 GENE EDITING MARKET FOR ANTISENSE, BY REGION, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 EUROPE: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 ASIA PACIFIC: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 LATIN AMERICA: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 OTHER TECHNOLOGIES
TABLE 50 GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 LATIN AMERICA: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
8 GENE EDITING MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 55 GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 CELL LINE ENGINEERING
8.2.1 INCREASING RESEARCH APPLICATIONS TO PROMOTE MARKET GROWTH
TABLE 56 GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2021–2028 (USD MILLION)
TABLE 57 NORTH AMERICA: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 EUROPE: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 59 ASIA PACIFIC: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 60 LATIN AMERICA: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 GENETIC ENGINEERING
8.3.1 GROWING USE OF ANIMAL SIMULATION MODELS IN RESEARCH AND INCREASING INTEREST IN GM CROPS TO DRIVE MARKET
TABLE 61 GENE EDITING MARKET FOR GENETIC ENGINEERING, BY REGION, 2021–2028 (USD MILLION)
TABLE 62 NORTH AMERICA: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 ASIA PACIFIC: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 LATIN AMERICA: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 DRUG DISCOVERY & DEVELOPMENT
8.4.1 GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO BOOST GROWTH
TABLE 66 GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION)
TABLE 67 NORTH AMERICA: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 EUROPE: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 ASIA PACIFIC: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 LATIN AMERICA: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 OTHER APPLICATIONS
TABLE 71 GENE EDITING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 72 NORTH AMERICA: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 EUROPE: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 LATIN AMERICA: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 GENE EDITING MARKET, BY END USER
9.1 INTRODUCTION
TABLE 76 GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMA & BIOTECH COMPANIES TO HOLD LARGEST MARKET SHARE
TABLE 77 GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 78 NORTH AMERICA: GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 EUROPE: GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: GENE EDITING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 81 LATIN AMERICA: GENE EDITING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 ACADEMIC & RESEARCH INSTITUTES
9.3.1 TREND OF COLLABORATIVE RESEARCH TO SUPPORT MARKET GROWTH
TABLE 82 GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 83 NORTH AMERICA: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 EUROPE: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 85 ASIA PACIFIC: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 LATIN AMERICA: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 OTHER END USERS
TABLE 87 GENE EDITING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 88 NORTH AMERICA: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 EUROPE: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 LATIN AMERICA: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
10 GENE EDITING MARKET, BY REGION
10.1 INTRODUCTION
TABLE 92 GENE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 26 NORTH AMERICA: GENE EDITING MARKET SNAPSHOT
TABLE 93 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 NORTH AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 95 NORTH AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 96 NORTH AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 US
10.2.2.1 Robust investment to drive market growth
TABLE 98 US: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 99 US: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 100 US: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 101 US: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Availability of research funding to support growth
TABLE 102 CANADA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 103 CANADA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 104 CANADA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 105 CANADA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
TABLE 106 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 EUROPE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 108 EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 109 EUROPE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Strong academic base and rising awareness to boost market
TABLE 111 GERMANY: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 112 GERMANY: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 113 GERMANY: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 114 GERMANY: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 UK
10.3.3.1 Government support to boost market growth
TABLE 115 UK: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 116 UK: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 117 UK: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 118 UK: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Government funding for genomics and rising research investments to propel market
TABLE 119 FRANCE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 120 FRANCE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 121 FRANCE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 122 FRANCE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Increasing collaborations to drive genomic medicine research and favor market
TABLE 123 ITALY: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 124 ITALY: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 125 ITALY: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 126 ITALY: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Proactive research funding to boost market
TABLE 127 SPAIN: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 128 SPAIN: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 129 SPAIN: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 130 SPAIN: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 131 REST OF EUROPE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 132 REST OF EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 133 REST OF EUROPE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 134 REST OF EUROPE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 27 ASIA PACIFIC: GENE EDITING MARKET SNAPSHOT
TABLE 135 ASIA PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 ASIA PACIFIC: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 138 ASIA PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 139 ASIA PACIFIC: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 CHINA
10.4.2.1 China to hold largest share of APAC market
TABLE 140 CHINA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 141 CHINA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 142 CHINA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 143 CHINA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Focus on cancer research to showcase favorable scenarios for gene editing market
TABLE 144 JAPAN: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 145 JAPAN: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 146 JAPAN: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 147 JAPAN: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Growing startups and government support to boost growth potential
TABLE 148 INDIA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 149 INDIA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 150 INDIA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 151 INDIA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 152 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 153 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 154 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 155 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 156 LATIN AMERICA: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 157 LATIN AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 158 LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 159 LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 160 LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 BRAZIL
10.5.2.1 Brazil to dominate Latin American market
TABLE 161 BRAZIL: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 162 BRAZIL: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 163 BRAZIL: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 164 BRAZIL: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 165 REST OF LATIN AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 166 REST OF LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 167 REST OF LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 168 REST OF LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.4 MIDDLE EAST & AFRICA
10.5.4.1 Increasing adoption of genetic testing to propel market
10.5.5 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 169 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 171 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 172 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 28 KEY PLAYER STRATEGIES, 2020–2023
11.3 MARKET SHARE ANALYSIS
TABLE 173 GENE EDITING MARKET: DEGREE OF COMPETITION
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 30 REVENUE ANALYSIS OF TOP FOUR MARKET PLAYERS (2020–2022)
11.5 COMPANY EVALUATION QUADRANT, 2022
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 EMERGING COMPANIES
FIGURE 31 GENE EDITING MARKET: COMPANY EVALUATION QUADRANT, 2022
11.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 32 GENE EDITING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022
11.7 COMPANY FOOTPRINT ANALYSIS
11.7.1 PRODUCT/SERVICE FOOTPRINT ANALYSIS
TABLE 174 PRODUCT/SERVICE FOOTPRINT ANALYSIS: GENE EDITING MARKET (2022)
11.7.2 GEOGRAPHIC FOOTPRINT ANALYSIS
TABLE 175 GEOGRAPHIC FOOTPRINT ANALYSIS: GENE EDITING MARKET (2022)
11.8 COMPETITIVE SCENARIO
12 COMPANY PROFILES
12.1 KEY COMPANIES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 THERMO FISHER SCIENTIFIC
TABLE 176 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
12.1.2 MERCK KGAA
TABLE 177 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2022)
12.1.3 GENSCRIPT
TABLE 178 GENSCRIPT: BUSINESS OVERVIEW
FIGURE 35 GENSCRIPT: COMPANY SNAPSHOT (2022)
12.1.4 AGILENT TECHNOLOGIES
TABLE 179 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW
FIGURE 36 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2022)
12.1.5 PERKINELMER
TABLE 180 PERKINELMER: BUSINESS OVERVIEW
FIGURE 37 PERKINELMER: COMPANY SNAPSHOT (2022)
12.1.6 LONZA
TABLE 181 LONZA: BUSINESS OVERVIEW
FIGURE 38 LONZA: COMPANY SNAPSHOT (2022)
12.1.7 TECAN LIFE SCIENCES
TABLE 182 TECAN LIFESCIENCES: BUSINESS OVERVIEW
FIGURE 39 TECAN LIFESCIENCES: COMPANY SNAPSHOT (2022)
12.1.8 SANGAMO THERAPEUTICS
TABLE 183 SANGAMO THERAPEUTICS: BUSINESS OVERVIEW
FIGURE 40 SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2022)
12.1.9 EDITAS MEDICINE
TABLE 184 EDITAS MEDICINE: BUSINESS OVERVIEW
FIGURE 41 EDITAS MEDICINE: COMPANY SNAPSHOT (2022)
12.1.10 CRISPR THERAPEUTICS AG
TABLE 185 CRISPR THERAPEUTICS AG: BUSINESS OVERVIEW
FIGURE 42 CRISPR THERAPEUTICS AG: COMPANY SNAPSHOT (2022)
12.1.11 PRECISION BIOSCIENCES
TABLE 186 PRECISION BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 43 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2020)
12.1.12 CELLECTIS S.A.
TABLE 187 CELLECTIS: BUSINESS OVERVIEW
FIGURE 44 CELLECTIS: COMPANY SNAPSHOT (2022)
12.1.13 INTELLIA THERAPEUTICS
TABLE 188 INTELLIA THERAPEUTICS: BUSINESS OVERVIEW
FIGURE 45 INTELLIA THERAPEUTICS: COMPANY SNAPSHOT (2022)
12.1.14 BLUEBIRD BIO INC.
TABLE 189 BLUEBIRD BIO: BUSINESS OVERVIEW
FIGURE 46 BLUEBIRD BIO: COMPANY SNAPSHOT (2022)
12.1.15 REGENERON PHARMACEUTICALS INC.
TABLE 190 REGENERON PHARMACEUTICALS: BUSINESS OVERVIEW
FIGURE 47 REGENERON PHARMACEUTICALS: COMPANY SNAPSHOT (2022)
12.1.16 AMSBIO
TABLE 191 AMSBIO: BUSINESS OVERVIEW
12.1.17 CREATIVE BIOGENE
TABLE 192 CREATIVE BIOGENE: BUSINESS OVERVIEW
12.1.18 SYNTHEGO CORPORATION
TABLE 193 SYNTHEGO CORPORATION: BUSINESS OVERVIEW
12.1.19 BEAM THERAPEUTICS
TABLE 194 BEAM THERAPEUTICS: BUSINESS OVERVIEW
FIGURE 48 BEAM THERAPEUTICS: COMPANY SNAPSHOT (2022)
12.2 OTHER PLAYERS
12.2.1 CARIBOU BIOSCIENCES
12.2.2 ORIGENE TECHNOLOGIES
12.2.3 NEW ENGLAND BIOLABS
12.2.4 INSCRIPTA
12.2.5 MAMMOTH BIOSCIENCES
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: GENE EDITING MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 GENE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 GENE EDITING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
FIGURE 7 GENE EDITING MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
2.4 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 9 GENE EDITING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 GENE EDITING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 11 GENE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 12 GENE EDITING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT: GENE EDITING MARKET, 2022
4 PREMIUM INSIGHTS
4.1 GENE EDITING MARKET OVERVIEW
FIGURE 14 GROWING INVESTMENTS IN GENOMICS RESEARCH TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 15 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 NORTH AMERICA GENE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 16 CELL LINE ENGINEERING TO DOMINATE NORTH AMERICAN MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 GENOME EDITING MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising government funding and number of genomics projects
5.2.1.2 Growing applications of genomics
5.2.1.3 Introduction of CRISPR-Cas9
5.2.2 RESTRAINTS
5.2.2.1 Off-target effects of CRISPR technology
5.2.3 OPPORTUNITIES
5.2.3.1 Extensive use of genome editing in personalized medicine
5.2.3.2 Expanding pipeline for gene therapy
5.2.4 CHALLENGES
5.2.4.1 High equipment costs
5.3 TECHNOLOGY ANALYSIS
5.4 SUPPLY AND VALUE CHAIN ANALYSIS
5.4.1 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 18 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS
5.4.2 VALUE CHAIN ANALYSIS
FIGURE 19 GENE EDITING MARKET: VALUE CHAIN ANALYSIS
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.6 PRICING ANALYSIS
TABLE 5 AVERAGE SELLING PRICES, BY PRODUCT (KEY PLAYER OFFERINGS)
5.7 REGULATORY ANALYSIS
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 ECOSYSTEM ANALYSIS
FIGURE 21 GENE EDITING MARKET: ECOSYSTEM ANALYSIS
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 11 GENE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY CONFERENCES AND EVENTS IN 2023
TABLE 12 GENE EDITING MARKET: CONFERENCES AND EVENTS (2023)
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 22 GENE EDITING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
5.11.2 GENE EDITING MARKET: BUYING CRITERIA
FIGURE 23 KEY BUYING CRITERIA FOR GENE EDITING
5.12 PATENT ANALYSIS
FIGURE 24 PATENTS GRANTED, JANUARY 2011–JUNE 2023
FIGURE 25 TOP PATENT APPLICANTS, JANUARY 2011–JUNE 2023
6 GENE EDITING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 13 GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 REAGENTS & CONSUMABLES
6.2.1 REAGENTS & CONSUMABLES TO HOLD LARGEST MARKET SHARE
TABLE 14 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 15 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 16 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 17 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 SOFTWARE & SYSTEMS
6.3.1 INCREASING APPLICATIONS OF GENOME EDITING/SEQUENCING TO BOOST DEMAND FOR SYSTEMS AND SOFTWARE
TABLE 19 GENE EDITING SOFTWARE & SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 20 NORTH AMERICA: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 EUROPE: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 ASIA PACIFIC: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 LATIN AMERICA: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SERVICES
6.4.1 RISING DEMAND FOR SERVICES TO SUPPORT GROWTH
TABLE 24 GENE EDITING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 25 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 GENE EDITING MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 29 GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.2 CRISPR
7.2.1 EASE OF USE TO BOOST DEMAND OVER OTHER TECHNOLOGIES
TABLE 30 GENE EDITING MARKET FOR CRISPR, BY REGION, 2021–2028 (USD MILLION)
TABLE 31 NORTH AMERICA: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 EUROPE: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 ASIA PACIFIC: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 LATIN AMERICA: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 TALEN
7.3.1 ABILITY TO MAKE QUICK MODIFICATIONS TO DRIVE USAGE
TABLE 35 GENE EDITING MARKET FOR TALEN, BY REGION, 2021–2028 (USD MILLION)
TABLE 36 NORTH AMERICA: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 EUROPE: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 ASIA PACIFIC: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 LATIN AMERICA: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 ZFN
7.4.1 UTILITY IN EUKARYOTE CELL STUDIES TO DRIVE MARKET GROWTH
TABLE 40 GENE EDITING MARKET FOR ZFN, BY REGION, 2021–2028 (USD MILLION)
TABLE 41 NORTH AMERICA: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 EUROPE: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 LATIN AMERICA: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 ANTISENSE
7.5.1 INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH
TABLE 45 GENE EDITING MARKET FOR ANTISENSE, BY REGION, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 EUROPE: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 ASIA PACIFIC: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 LATIN AMERICA: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 OTHER TECHNOLOGIES
TABLE 50 GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 LATIN AMERICA: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
8 GENE EDITING MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 55 GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 CELL LINE ENGINEERING
8.2.1 INCREASING RESEARCH APPLICATIONS TO PROMOTE MARKET GROWTH
TABLE 56 GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2021–2028 (USD MILLION)
TABLE 57 NORTH AMERICA: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 EUROPE: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 59 ASIA PACIFIC: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 60 LATIN AMERICA: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 GENETIC ENGINEERING
8.3.1 GROWING USE OF ANIMAL SIMULATION MODELS IN RESEARCH AND INCREASING INTEREST IN GM CROPS TO DRIVE MARKET
TABLE 61 GENE EDITING MARKET FOR GENETIC ENGINEERING, BY REGION, 2021–2028 (USD MILLION)
TABLE 62 NORTH AMERICA: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 ASIA PACIFIC: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 LATIN AMERICA: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 DRUG DISCOVERY & DEVELOPMENT
8.4.1 GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO BOOST GROWTH
TABLE 66 GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION)
TABLE 67 NORTH AMERICA: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 EUROPE: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 ASIA PACIFIC: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 LATIN AMERICA: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 OTHER APPLICATIONS
TABLE 71 GENE EDITING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 72 NORTH AMERICA: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 EUROPE: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 LATIN AMERICA: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 GENE EDITING MARKET, BY END USER
9.1 INTRODUCTION
TABLE 76 GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMA & BIOTECH COMPANIES TO HOLD LARGEST MARKET SHARE
TABLE 77 GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 78 NORTH AMERICA: GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 EUROPE: GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: GENE EDITING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 81 LATIN AMERICA: GENE EDITING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 ACADEMIC & RESEARCH INSTITUTES
9.3.1 TREND OF COLLABORATIVE RESEARCH TO SUPPORT MARKET GROWTH
TABLE 82 GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 83 NORTH AMERICA: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 EUROPE: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 85 ASIA PACIFIC: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 LATIN AMERICA: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 OTHER END USERS
TABLE 87 GENE EDITING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 88 NORTH AMERICA: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 EUROPE: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 LATIN AMERICA: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
10 GENE EDITING MARKET, BY REGION
10.1 INTRODUCTION
TABLE 92 GENE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 26 NORTH AMERICA: GENE EDITING MARKET SNAPSHOT
TABLE 93 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 NORTH AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 95 NORTH AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 96 NORTH AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 US
10.2.2.1 Robust investment to drive market growth
TABLE 98 US: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 99 US: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 100 US: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 101 US: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Availability of research funding to support growth
TABLE 102 CANADA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 103 CANADA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 104 CANADA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 105 CANADA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
TABLE 106 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 EUROPE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 108 EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 109 EUROPE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Strong academic base and rising awareness to boost market
TABLE 111 GERMANY: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 112 GERMANY: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 113 GERMANY: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 114 GERMANY: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 UK
10.3.3.1 Government support to boost market growth
TABLE 115 UK: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 116 UK: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 117 UK: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 118 UK: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Government funding for genomics and rising research investments to propel market
TABLE 119 FRANCE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 120 FRANCE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 121 FRANCE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 122 FRANCE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Increasing collaborations to drive genomic medicine research and favor market
TABLE 123 ITALY: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 124 ITALY: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 125 ITALY: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 126 ITALY: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Proactive research funding to boost market
TABLE 127 SPAIN: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 128 SPAIN: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 129 SPAIN: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 130 SPAIN: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 131 REST OF EUROPE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 132 REST OF EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 133 REST OF EUROPE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 134 REST OF EUROPE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 27 ASIA PACIFIC: GENE EDITING MARKET SNAPSHOT
TABLE 135 ASIA PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 ASIA PACIFIC: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 138 ASIA PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 139 ASIA PACIFIC: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 CHINA
10.4.2.1 China to hold largest share of APAC market
TABLE 140 CHINA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 141 CHINA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 142 CHINA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 143 CHINA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Focus on cancer research to showcase favorable scenarios for gene editing market
TABLE 144 JAPAN: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 145 JAPAN: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 146 JAPAN: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 147 JAPAN: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Growing startups and government support to boost growth potential
TABLE 148 INDIA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 149 INDIA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 150 INDIA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 151 INDIA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 152 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 153 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 154 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 155 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 156 LATIN AMERICA: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 157 LATIN AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 158 LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 159 LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 160 LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 BRAZIL
10.5.2.1 Brazil to dominate Latin American market
TABLE 161 BRAZIL: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 162 BRAZIL: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 163 BRAZIL: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 164 BRAZIL: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 165 REST OF LATIN AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 166 REST OF LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 167 REST OF LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 168 REST OF LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.4 MIDDLE EAST & AFRICA
10.5.4.1 Increasing adoption of genetic testing to propel market
10.5.5 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 169 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 171 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 172 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 28 KEY PLAYER STRATEGIES, 2020–2023
11.3 MARKET SHARE ANALYSIS
TABLE 173 GENE EDITING MARKET: DEGREE OF COMPETITION
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 30 REVENUE ANALYSIS OF TOP FOUR MARKET PLAYERS (2020–2022)
11.5 COMPANY EVALUATION QUADRANT, 2022
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 EMERGING COMPANIES
FIGURE 31 GENE EDITING MARKET: COMPANY EVALUATION QUADRANT, 2022
11.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 32 GENE EDITING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022
11.7 COMPANY FOOTPRINT ANALYSIS
11.7.1 PRODUCT/SERVICE FOOTPRINT ANALYSIS
TABLE 174 PRODUCT/SERVICE FOOTPRINT ANALYSIS: GENE EDITING MARKET (2022)
11.7.2 GEOGRAPHIC FOOTPRINT ANALYSIS
TABLE 175 GEOGRAPHIC FOOTPRINT ANALYSIS: GENE EDITING MARKET (2022)
11.8 COMPETITIVE SCENARIO
12 COMPANY PROFILES
12.1 KEY COMPANIES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 THERMO FISHER SCIENTIFIC
TABLE 176 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
12.1.2 MERCK KGAA
TABLE 177 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2022)
12.1.3 GENSCRIPT
TABLE 178 GENSCRIPT: BUSINESS OVERVIEW
FIGURE 35 GENSCRIPT: COMPANY SNAPSHOT (2022)
12.1.4 AGILENT TECHNOLOGIES
TABLE 179 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW
FIGURE 36 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2022)
12.1.5 PERKINELMER
TABLE 180 PERKINELMER: BUSINESS OVERVIEW
FIGURE 37 PERKINELMER: COMPANY SNAPSHOT (2022)
12.1.6 LONZA
TABLE 181 LONZA: BUSINESS OVERVIEW
FIGURE 38 LONZA: COMPANY SNAPSHOT (2022)
12.1.7 TECAN LIFE SCIENCES
TABLE 182 TECAN LIFESCIENCES: BUSINESS OVERVIEW
FIGURE 39 TECAN LIFESCIENCES: COMPANY SNAPSHOT (2022)
12.1.8 SANGAMO THERAPEUTICS
TABLE 183 SANGAMO THERAPEUTICS: BUSINESS OVERVIEW
FIGURE 40 SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2022)
12.1.9 EDITAS MEDICINE
TABLE 184 EDITAS MEDICINE: BUSINESS OVERVIEW
FIGURE 41 EDITAS MEDICINE: COMPANY SNAPSHOT (2022)
12.1.10 CRISPR THERAPEUTICS AG
TABLE 185 CRISPR THERAPEUTICS AG: BUSINESS OVERVIEW
FIGURE 42 CRISPR THERAPEUTICS AG: COMPANY SNAPSHOT (2022)
12.1.11 PRECISION BIOSCIENCES
TABLE 186 PRECISION BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 43 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2020)
12.1.12 CELLECTIS S.A.
TABLE 187 CELLECTIS: BUSINESS OVERVIEW
FIGURE 44 CELLECTIS: COMPANY SNAPSHOT (2022)
12.1.13 INTELLIA THERAPEUTICS
TABLE 188 INTELLIA THERAPEUTICS: BUSINESS OVERVIEW
FIGURE 45 INTELLIA THERAPEUTICS: COMPANY SNAPSHOT (2022)
12.1.14 BLUEBIRD BIO INC.
TABLE 189 BLUEBIRD BIO: BUSINESS OVERVIEW
FIGURE 46 BLUEBIRD BIO: COMPANY SNAPSHOT (2022)
12.1.15 REGENERON PHARMACEUTICALS INC.
TABLE 190 REGENERON PHARMACEUTICALS: BUSINESS OVERVIEW
FIGURE 47 REGENERON PHARMACEUTICALS: COMPANY SNAPSHOT (2022)
12.1.16 AMSBIO
TABLE 191 AMSBIO: BUSINESS OVERVIEW
12.1.17 CREATIVE BIOGENE
TABLE 192 CREATIVE BIOGENE: BUSINESS OVERVIEW
12.1.18 SYNTHEGO CORPORATION
TABLE 193 SYNTHEGO CORPORATION: BUSINESS OVERVIEW
12.1.19 BEAM THERAPEUTICS
TABLE 194 BEAM THERAPEUTICS: BUSINESS OVERVIEW
FIGURE 48 BEAM THERAPEUTICS: COMPANY SNAPSHOT (2022)
12.2 OTHER PLAYERS
12.2.1 CARIBOU BIOSCIENCES
12.2.2 ORIGENE TECHNOLOGIES
12.2.3 NEW ENGLAND BIOLABS
12.2.4 INSCRIPTA
12.2.5 MAMMOTH BIOSCIENCES
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
The global genome editing market is expected to reach $3,514.08 Million by 2019 from $1,845.25 Million in 2014, growing at a CAGR of 13.75%.
Increased R&D expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, and technological advancements are the primary growth drivers for this market during the forecast period (2014–2019). Moreover, increasing demand for synthetic genes, and global rise in production of genetically modified crops are also expected to drive market growth. However, stringent regulatory policies and adverse public perception related to genetic research may hinder the growth of this market.
The global genome editing market is segmented on the basis of applications, technologies and end users.
On the basis of applications, the market is segmented into cell line engineering, animal genetic engineering, plant genetic engineering, and other applications. Of these, the cell line engineering segment accounted for the largest share of the global genome editing market in 2014. On the other hand, the animal genetic engineering segment is expected to grow at the highest growth rate during the forecast period.
By technology, the market is divided into CRISPR, TALEN, ZNF, antisense technology, and other technologies. Of these, CRISPR will account for the largest and the fastest-growing segment of the global genome editing market by 2019. On the basis of end users, the genome editing market is categorized into biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations (CROs).
The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). North America includes Canada and the U.S.; and Asia includes China, India, Japan, and the Rest of Asia.
Major players of Genome Editing Market are
- GenScript USA Inc. (U.S.)
- Integrated DNA Technologies, Inc. (U.S.)
- New England Biolabs, Inc. (U.S.)
- OriGene Technologies, Inc. (U.S.)
- Sangamo Biosciences, Inc. (U.S.)
